Continuation of d10: onyx frontier stent.Date of use (b)(6) 2023.Lot number not collected by study.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
During the index procedure one resolute onyx drug eluting stent was implanted in the right coronary artery (rca).During the index procedure, one launcher guide catheter and one export ap aspiration catheter were also used.During the procedure the patient was undergoing thrombus aspiration, which removed a lot of red thrombus and restored nice flow.The aspiration catheter was able to aspirate the thrombus.However the patient became bradycardic and hypotensive.The patient was treated with medication and iv fluids.The patients blood pressure responded well.The patient was also treated with a percutaneous transluminal coronary intervention.The patient was taking dual antiplatelet therapy within 24 hours prior to the event.The patient recovered.It was stated that the rationale for the relationship to the system or procedure was that the patient was experiencing stemi with a high thrombus burden in the proximal rca.
|